Do you have the same question? Follow this Question
Oct 23, 2025 - 11:03 AM
We’ve provided several answers to questions related to Epclusa (Sofosbuvir/Velpatasvir) , see some other helpful Q&A related to this product.
Question: What are the DrugBank identifiers for sofosbuvir and velpatasvir?
Answer: The DrugBank identifier for sofosbuvir is DB08934, and for velpatasvir, it is DB11613. DrugBank IDs allow researchers and clinicians to access detailed information about the drugs, which can be valuable for understanding drug interactions and mechanisms.
Question: What is the protein binding percentage of velpatasvir?
Answer: Velpatasvir has a protein binding greater than 99.5%. High protein binding means that most of the drug is carried in the blood attached to proteins, which can impact its distribution and duration of effect.
Question: What is the route of administration for this medication?
Answer: This medication is taken orally as a tablet. Oral administration is convenient and non-invasive, which can help improve patient compliance with treatment.
View all Epclusa (Sofosbuvir/Velpatasvir) Questions & Answers
